Merck & Co., Inc. (MRK) fundamentals from SEC filings — revenue $65.0B, net margin 28.1%, diluted EPS $7.28 in FY2025. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $48.7B | $59.3B | $60.1B | $64.2B | $65.0B |
| Net income | $13.0B | $14.5B | $365.0M | $17.1B | $18.3B |
| Net margin | 26.8% | 24.5% | 0.6% | 26.7% | 28.1% |
| Diluted EPS | $5.14 | $5.71 | $0.14 | $6.74 | $7.28 |
| Free cash flow | $8.7B | $14.7B | $9.1B | $18.1B | $12.4B |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home